Steve Beuchaw
Stock Analyst at Morgan Stanley
(1.59)
# 2,229
Out of 4,413 analysts
78
Total ratings
60.87%
Success rate
6.88%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Upgrades: Overweight | $49 → $51 | $42.33 | +20.48% | 1 | Feb 16, 2024 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $137.04 | - | 12 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $282.38 | +172.68% | 10 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $78.01 | - | 7 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | n/a | $69.28 | - | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | n/a | $30.01 | - | 4 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | n/a | $123.05 | - | 8 | Jan 7, 2019 | |
| TMO Thermo Fisher | Maintains: Overweight | n/a | $568.72 | - | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | n/a | $309.04 | - | 6 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | n/a | $19.57 | - | 8 | Oct 10, 2018 | |
| NTRA Natera | Maintains: Overweight | n/a | $92.88 | - | 4 | Sep 28, 2018 | |
| BIO Bio-Rad Laboratories | Initiates: Equal-Weight | n/a | $269.75 | - | 1 | Sep 20, 2018 | |
| PDCO Patterson Companies | Maintains: Underweight | n/a | $25.47 | - | 5 | Aug 31, 2018 | |
| TTOO T2 Biosystems | Downgrades: Underweight | $30,000 → $25,000 | $3.36 | +745,056.48% | 1 | Mar 15, 2017 |
Qiagen
Feb 16, 2024
Upgrades: Overweight
Price Target: $49 → $51
Current: $42.33
Upside: +20.48%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $137.04
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $282.38
Upside: +172.68%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $78.01
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: n/a
Current: $69.28
Upside: -
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: n/a
Current: $30.01
Upside: -
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: n/a
Current: $123.05
Upside: -
Thermo Fisher
Oct 25, 2018
Maintains: Overweight
Price Target: n/a
Current: $568.72
Upside: -
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $309.04
Upside: -
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: n/a
Current: $19.57
Upside: -
Natera
Sep 28, 2018
Maintains: Overweight
Price Target: n/a
Current: $92.88
Upside: -
Bio-Rad Laboratories
Sep 20, 2018
Initiates: Equal-Weight
Price Target: n/a
Current: $269.75
Upside: -
Patterson Companies
Aug 31, 2018
Maintains: Underweight
Price Target: n/a
Current: $25.47
Upside: -
T2 Biosystems
Mar 15, 2017
Downgrades: Underweight
Price Target: $30,000 → $25,000
Current: $3.36
Upside: +745,056.48%